Humacyte extends gains as FDA reviews blood vessel product
NewsToday, 7:28 AM
HUMA Humacyte, Inc.
$5.480.78(+16.60%)4:00 PM 05/13/24
NASDAQ |$USD |Pre-Market:$5.80+0.32(+5.84%)7:10 AM
What the FDA does is a crap shoot but this stock had insider selling at $2.78/
Niklason Laura E
President...